secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGENUS INC (AGEN)
CIK:        0001098972
Form:       8-K
Filed at:   2026-05-11T12:52:03+00:00
Accession:  0001193125-26-215838
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Agenus Q1 net income $39.2M, revenue $33.7M; SEC closes investigation with no action
--------------------------------------------------------------------------------

- Net income of $39.2M vs loss of $26.4M in Q1 2025; total revenue $33.7M (+40% YoY).
- Cash rose to $35.0M at March 31, 2026 from $3.0M at Dec 31, 2025, boosted by Zydus deal proceeds.
- Zydus collaboration closed Jan 2026 providing $91M upfront; Phase 3 BATTMAN trial began enrolling in April.
- SEC concluded its investigation with no enforcement action (May 2026); related class action dismissed in March.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1098972/000119312526215838/0001193125-26-215838-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1098972/000119312526215838/agen-20260511.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-215838

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer